Bortezomib for the Treatment of Refractory Rheumatoid Arthritis
Clinical trial NCT05805891 · UNKNOWN
Trial details
- NCT number
- NCT05805891
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2025-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.